An Investigational Drug Study in Adults With Type 2 Diabetes on Basal Insulin (MK-0941-006)

NCT00511472 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

70

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: MK-0941
DRUG: Placebo
DRUG: LANTUS insulin

Sponsor

Merck Sharp & Dohme LLC